Gilead Sciences Inc.

NASDAQ: GILD · Real-Time Price · USD
118.46
-0.56 (-0.47%)
At close: Aug 15, 2025, 1:10 PM

Gilead Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.99B 6.08B 5.41B 5.34B
Short-Term Investments
1.58B 1.18B 973M 1.18B
Long-Term Investments
n/a 1.16B 1.25B 1.31B
Other Long-Term Assets
6.15B 4.79B 4.8B 4.96B
Receivables
4.42B 4.66B 4.78B 4.49B
Inventory
1.71B 1.79B 1.51B 1.62B
Other Current Assets
995M 2.37B n/a n/a
Total Current Assets
19.17B 16.09B 14.44B 14.77B
Property-Plant & Equipment
5.41B 5.32B 5.47B 5.12B
Goodwill & Intangibles
28.26B 34.77B 37.21B 41.79B
Total Long-Term Assets
39.82B 46.04B 48.73B 53.18B
Total Assets
58.99B 62.13B 63.17B 67.95B
Account Payables
833M 550M 905M 705M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.81B 1.8B 2.27B 1.52B
Other Current Liabilities
3.82B 3.92B 3.62B 1.43B
Total Current Liabilities
12B 11.28B 11.24B 11.61B
Long-Term Debt
24.9B 23.19B 22.96B 25.18B
Other Long-Term Liabilities
2.13B 3.32B 5.09B 5.74B
Total Long-Term Liabilities
27.75B 28.1B 30.72B 35.28B
Total Liabilities
39.75B 39.38B 41.96B 46.89B
Total Debt
26.71B 24.99B 25.23B 26.7B
Common Stock
1M 1M 1M 1M
Retained Earnings
11.5B 16.3B 15.69B 16.32B
Comprehensive Income
132M 28M 2M 83M
Shareholders Equity
19.33B 22.83B 21.24B 21.07B
Total Investments
1.58B 2.34B 2.22B 2.49B